CSL Limited (CSLLY)
Data as of September 4, 2026 · Biotechnology
Stockbruh grade: Challenging 1/5 metrics rated Sunny
What does CSL Limited do?
CSL Limited is a biopharmaceutical company that researches, develops, and distributes life-saving plasma therapies and biotherapeutic products. With headquarters in Parkville, Australia, they are dedicated to improving the health and well-being of people around the world. 🌍💉🔬.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛈️ Weak | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛅ Moderate | Revenue & earnings trend |
| Earnings | ⛅ Moderate | EPS vs analyst expectations |
| Cash & Debt | ⛅ Moderate | Balance sheet strength |
| Price | $31.70 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Returns have been below average recently — worth reviewing valuation carefully before investing. Sign up free to see the full Stockbruh valuation breakdown.
How the business works
CSL Limited is a biopharmaceutical company that researches, develops, and distributes life-saving plasma therapies and biotherapeutic products. With headquarters in Parkville, Australia, they are dedicated to improving the health and well-being of people around the world. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth is mixed — some positive signals, but not consistent. Sign up free for Stockbruh's full growth breakdown.
What's ahead?
Earnings are mixed. Sign up free for the full earnings picture including EPS history and analyst forecasts.